GLP-2 TRZ 10mg – Complete Kit

The GLP-2 TRZ Complete Kit combines a 10mg dual incretin receptor agonist lyophilized vial with all the essential preparation and administration accessories required for immediate research use: bacteriostatic water for reconstitution, syringes, needles, and alcohol wipes supplied as a single complete package. This all in one kit format eliminates the need to source reconstitution supplies and administration accessories separately, providing a streamlined entry point into dual GIP/GLP-1 incretin agonist research for researchers initiating protocols or evaluating compound performance for the first time.

The kit’s accessory bundle supports each stage of the preparation and administration workflow. Bacteriostatic water provides the sterile reconstitution medium required to bring the lyophilized peptide into solution while maintaining multi dose solution sterility across the vial’s usage period. Syringes and needles provide precise volume measurement and administration capability for accurate dose delivery from a reconstituted peptide solution. Alcohol wipes support aseptic technique at each preparation and administration step. The complete workflow from lyophilized vial through reconstitution and administration covered by a single kit procurement.

GLP-2 TRZ is a dual incretin receptor agonist simultaneously targeting glucagon like peptide 1 (GLP-1) and glucose dependent insulinotropic polypeptide (GIP) receptors. Not a GLP-2 receptor agonist as the product naming convention might suggest. GLP-1 receptor activation drives glucose dependent insulin secretion, pancreatic glucagon suppression, gastric emptying delay, and central nervous system satiety signaling. GIP receptor activation contributes complementary insulinotropic activity alongside adipose tissue metabolic effects and bone turnover research dimensions. The combined dual receptor profile producing a synergistic incretin response that positions GLP-2 TRZ as a more pharmacologically complex research tool than single receptor GLP-1 agonists like Semaglutide. The 10mg concentration of this Complete Kit matches the lowest single vial concentration in CSD’s GLP-2 TRZ range, making it the most accessible entry point into dual incretin agonist research with the added convenience of a fully equipped preparation system.

Every batch of CSD’s GLP-2 TRZ is third party lab tested for concentration accuracy and purity before being made available, with COA documentation available on request. Canada Steroid Depot has supplied Canadian customers with consistently verified, accurately dosed research compounds for years, and our dual incretin agonist range covers multiple concentrations and formats for complete research sourcing flexibility. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Store lyophilized vial at 2–8°C away from direct light. Reconstitute with provided bacteriostatic water prior to use. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside GLP-1 receptor agonist compounds and triple incretin agonists in comparative incretin pathway and metabolic activity studies. Browse CSD’s full peptide range for complete sourcing.